NKGN
Geode Capital Management’s NKGen Biotech, Inc. Common Stock NKGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-127,168
| Closed | -$83.3K | – | 4534 |
|
|
2024
Q4 | $83.3K | Buy |
127,168
+14,454
| +13% | +$9.47K | ﹤0.01% | 4143 |
|
|
2024
Q3 | $42.6K | Buy |
112,714
+44,275
| +65% | +$16.7K | ﹤0.01% | 4291 |
|
|
2024
Q2 | $86.9K | Buy |
68,439
+15,070
| +28% | +$19.1K | ﹤0.01% | 4172 |
|
|
2024
Q1 | $101K | Buy |
53,369
+7,519
| +16% | +$14.2K | ﹤0.01% | 4155 |
|
|
2023
Q4 | $126K | Buy |
+45,850
| New | +$126K | ﹤0.01% | 4105 |
|